This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
All content for Phase Forward is the property of Podcast Series hosted by Valerie Coveney and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
Episode 21: Maintaining clear and consistent communication among the sponsor, CRO, and site
Phase Forward
11 minutes 48 seconds
11 months ago
Episode 21: Maintaining clear and consistent communication among the sponsor, CRO, and site
In this episode, we welcome Laura Tomat, Senior Director and Project Management at Innovaderm, with over 25 years of experience in clinical trial management. Laura discusses the evolving nature of communication in clinical research, emphasizing the importance of transparency, optimizing communication, and personalizing interactions. She explores the economics of communication, balancing informative, concise, and accurate communication to benefit both sites and sponsors. Tune in for valuable insights into effective communication in clinical research.
Phase Forward
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
